You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 19 Next »

Summary

The TCGA Glioma Phenotype Research Group is part of the CIP TCGA Radiology Initiative. The group began as an ad hoc multi-institutional research team dedicated to discovering the value of applying controlled terminology to the MR imaging features of patients with gliomas.

Research trials that incorporate imaging present unique challenges due to nonstandard use of terminologies, absence of uniform data collection and validation. These obstacles traditionally limit the impact of imaging as an effective biomarker in oncology. The purpose of this project was to assess reliability of tools and terminology developed by the Cancer Bioinformatics Grid (caBIG) initiative when performing a multireader simultaneous assessments of glioblastoma MR imaging features.

A controlled terminology for describing the MR features of human gliomas was devised based upon prior work (VASARI / REMBRANDT project). This comprehensive featureset consists of 24 observations familiar to neuroradiologists to describe the morphology of brain tumors on routine contrast-enhanced MRI. The National Biomedical Imaging Archive (NBIA) was used to store the de-identified baseline MRI studies for 78 glioblastomas collected for The Cancer Genome Atlas (TCGA) initiative. Six neuroradiologists in three disparate geographic locations were recruited and trained in the use of the featureset using a visual guidebook. Training cases were employed to assess competency and to ensure agreement. A open-source PACS workstation (Clear Canvas) was customized for clinical imaging research evaluation and deployed at each of the three centers. Networking tools built into the workstation were used to securely download studies from NBIA (caGRID). As studies were evaluated, scores were simultaneously uplinked to a single remote AIM (Annotation and Image Markup) repository for QC checks and interim analysis. Case assignments were deliberately staged in a staggered fashion to ensure that a minimum of three evaluations were efficiently obtained. Administrative tools were employed by coordinators in a fourth location. Qualitative assessments included: (1) effectiveness of training, (2) ease of deployment & functionality of the informatics solutions and (3) efficiency of the process. Inter-observer variation for each feature was assessed with the generalized kappa statistic of Berry&Miekle.

Training, deployment of resources and completion of three evaluations per case were accomplished in 30 days. Functionality of the IT solutions was rated superior in qualitative assessment. The results indicated strong overall average inter-observer agreement among all six readers. Agreement was highest for tumor side (generalized kappa statistic k=0.943, 95% CI 0.915-0.982) and tumor location (k=0.837, 95% CI 0.807-0.902). Other features with high agreement included proportion enhancing tumor (k=0.656, 95% CI 0.596-0.757), presence of satellites (k=0.663, 95% CI 0.591-0.780), and diffusion (k=0.730, 95% CI 0.664-0.828). Of the remaining, only three features (12.5%) showed low agreement (k<0.4): presence of calvarial remodeling (k=0.366, 95% CI 0.124-0.626), cortical involvement (k=0.167, 95% CI 0.157-0.335), and definition of non-enhancing margin (k=0.374, 95% CI 0.347-0.514).

Inclusion of vetted, tested and validated controlled terminologies into imaging arms of clinical trials is essential in adding value of imaging as a biomarker in cross-cutting correlative studies. Controlled terminologies such as the one described herein for assessment of gliomas can be effectively used by domain experts following a relatively short training period. Technologies developed through the caBIG initiative provide an effective and efficient framework for federated imaging assessments that can expedite cross-correlative analysis with other data repositories (e.g. genomics / proteomics / pathology).

Updates to the TCGA-GBM imaging data set are being stored within TCIA and the research group is continuing to expand on their work. Please contact the CIP Informatics Team if your research group would like to be kept in the loop as this effort moves forward. You can reach us by emailing John Freymann or Justin Kirby at:

  • freymanj (at) mail (dot) nih (dot) gov
  • kirbyju (at) mail (dot) nih (dot) gov

Accepted Abstracts

RSNA 2011 (Nov 27-Dec 2, 2011, Chicago, IL)

Title

Supporting Materials

A Coordinated Method for Clinical Trials Research: Multireader Assessment of MR Imaging Features of Human Gliomas
A E Flanders, MD, Philadelphia, PA; E Huang, PhD; M Wintermark, MD; M Nicolas-Jilwan, MD; P Raghavan, MD; C A Holder, MD; et al.

Computer-aided Visual Image Analysis of Glioblastomas and Genomic Features
S N Hwang, PhD,MD, Atlanta, GA; C A Holder, MD; E Huang, PhD; R A Clifford; D Hammoud, MD; P Raghavan, MD; et al.

A Novel Statistical Method for Lossless Compression of Diagnostic Imaging Features
E Huang, PhD, Rockville, MD; J B Freymann, BS; J Kirby; R A Clifford; C Jaffe, MD; A E Flanders, MD

Prediction of Glioblastoma Multiforme (GBM) Time to Recurrence Using MRI Image Features and Gene Expression
_M nicolasjilwan, MD, charlottesville, VA; R A Clifford; A E Flanders, MD; L Scarpace; P Raghavan, MD; D Hammoud, MD; et al. _

Radiogenomic Mapping in GBM: A Novel Quantitative Merge between Imaging and Genomics - The Creation of a Signature for Tumor Necrosis Using Image Genomic Analysis in 12, 764 genes and 555 microRNAs
R R Colen, MD, Boston, MA; P O Zinn, MD; J R Bruyere, BS,MA; B Mahajan, MBBS; F A Jolesz, MD

ASNR 2011 (June 4-9, 2011, Seattle, WA)

Title

Supporting Materials

Relationship between MR Imaging Features, Gene Expression Subtype, and Histopathologic Features of Glioblastomas
Hwang SN, Clifford R, Huang E, Hammoud D, Jilwan M, Raghavan P, Wintermark M, Gutman DA, Moreno C, Cooper L, Freymann J, Kirby J, Krishnan A, Dehkharghani S, Jaffe C, Saltz JH, Flanders A, Brat DJ, Holder CA

Associations Between MR Imaging and Genomic Features of Glioblastomas
Hwang SN, Holder CA Huang E, Clifford R, Hammoud D, Raghavan P, Jilwan M, Wintermark M, Gutman DA, Cooper L, Moreno C, Kirby J, Freymann J, Dehkharghani S, Krishnan A, Jaffe C, Flanders A, Saltz JH, Brat DJ

A Methodology for Multi-reader Assessment of MR Imaging Features of Gliomas in Clinical Trials
Flanders, A. Huang E, Wintermark M, Hammoud D, Jilwan, M. Raghaven, Holder C, Hwang S, Clifford R, Freymann J, Kirby J, Jaffe C C

Prediction of Glioblastoma Multiforme (GBM) Patient Survival Using MRI Image Features and Gene Expression
Nicolasjilwan M, Clifford R, Raghavan P, Wintermark M, Hammoud D, Huang E, Jaffe C, Freymann J, Kirby J, Buetow K, Huang S, Holder C

caBIG Tools for TCGA-GBM Analysis

Informatics software for use with this data has also been developed as part of the caBIG TCGA Enterprise Use-Case project. This caBIG enterprise use-case enabled TCGA images stored in NBIA (the same software powering the Cancer Imaging Archive) to be displayed on three different free and/or open source DICOM viewer workstations that possess annotation and markup capabilities based on Annotation Imaging Markup (AIM).  These workstations were customized to allow retrieval of images from NBIA over the caGrid (from the NCI CBIIT deployed NBIA server only), markup by AIM standards, and storage back to an AIM-E Grid data service. Some of these tools have been leveraged as part of the CIP TCGA Radiology Initiative where possible.

  • No labels